CLINICAL_TRIALS
trial_result
· 2023-10-18
Clinical Trial Update: PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer [Phase 1]
Summary
Phase 1 clinical trial evaluating PSCA-CAR T cells in PSCA-positive metastatic castration-resistant prostate cancer; study is active not recruiting with results…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: City of Hope Medical Center | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-18